Avacta Life Sciences Limited
  • About
  • Therapeutics
  • Diagnostics
    • Diagnostics
    • What is an Affimer® ?
    • Key benefits
    • Applications
    • Custom Service
    • COVID-19
    • News
  • Investors
  • News
  • Careers
  • Contact
  • About
    • About Avacta
    • People
    • Scientific Resources
    • Intellectual Property
    • Virtual tour
  • Therapeutics
    • Therapeutics
    • Affimer®
    • pre|CISIONTM
    • Pipeline
    • Partnering
    • News
  • Diagnostics
    • Diagnostics
    • What is an Affimer® ?
    • Key benefits
    • Applications
    • Custom Service
    • COVID-19
    • News
  • Investors
    • Investors
    • CEO Welcome
    • Key information
    • Corporate Governance
    • Documents & Presentations
    • Share price
    • RNS News
  • News
  • Careers
    • CEO Welcome
    • Job vacancies
    • About Avacta
    • Benefits of working at Avacta
  • Contact
  • About
    • About Avacta
    • People
    • Scientific Resources
    • Intellectual Property
    • Virtual tour
  • Therapeutics
    • Therapeutics
    • Affimer®
    • pre|CISIONTM
    • Pipeline
    • Partnering
    • News
  • Diagnostics
    • Diagnostics
    • What is an Affimer® ?
    • Key benefits
    • Applications
    • Custom Service
    • COVID-19
    • News
  • Investors
    • Investors
    • CEO Welcome
    • Key information
    • Corporate Governance
    • Documents & Presentations
    • Share price
    • RNS News
  • News
  • Careers
    • CEO Welcome
    • Job vacancies
    • About Avacta
    • Benefits of working at Avacta
  • Contact
Home News Diagnostics Page 2
filter by: view all | Blogs | Diagnostics | Investors | Therapeutics

Diagnostics

02 Sep 2020

Avacta Expands Rapid SARS-CoV-2 Antigen Test Manufacturing Capacity

Diagnostics | Investors
07 Aug 2020

SARS-CoV-2 Rapid Antigen Test Clinical Collaboration

Diagnostics | Investors
06 Aug 2020

COVID-19 Rapid Antigen Test Manufacturing Partner

Diagnostics | Investors
22 Jul 2020

Update on Clinical Validation of Adeptrix COVID-19 Diagnostic Test

Diagnostics | Investors
13 Jul 2020

Collaboration with Integumen plc for Detection of SARS-COV-2 Coronavirus in Waste Water

Diagnostics | Investors
26 Jun 2020

Interview with Alastair Smith on Cytiva update

Diagnostics | Investors
25 Jun 2020

Responding to disease outbreaks – the importance of point-of-care diagnostics

Blogs | Diagnostics
24 Jun 2020

Update on COVID-19 Rapid Antigen Test Development Partnership with Cytiva

Diagnostics | Investors
23 Jun 2020

How diagnostic test performance is measured

Diagnostics | Investors
19 Jun 2020

European Biopharmaceutical Review COVID-19 diagnostics article

Blogs | Diagnostics

Posts navigation

Older posts
Newer posts
Avacta Life Sciences Limited
  • Terms of Use
  • Terms & Conditions
  • Privacy Policy
  • Intellectual Property
  • Returns & cancellations policy
  • Corporate Responsibility
  • Contact Us
  • Avacta Animal Health

Avacta Life Sciences Ltd

Unit 20, Ash Way
Thorp Arch Estate
Wetherby
LS23 7FA
+44 (0)1904 21 7070

virtual tour
email

Avacta Cambridge

Unit B, 1 Lion Works
Station Road East
Whittlesford
Cambridge
CB22 4WL

virtual tour
email

FTI Consulting

200 Aldersgate
Aldersgate Street
London
EC1A 4HD

+44 (0)20 3727 1000

email

Twitter | Linkedin

©2021 Avacta Life Sciences Limited. Registered company no. 06605196. Affimer® is a registered trade mark.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok